BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$349,180
-$19,890 QoQ
Shares Held
221,000
0.0% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. LCTX ranks #50 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
528,698 | $8,697,082 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
775,341 | $4,954,428 | |
| 3 | EXEL |
Exelixis, Inc.
|
66,100 | $2,835,029 | |
| 4 | KROS |
Keros Therapeutics, Inc.
|
195,017 | $2,152,987 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
299,641 | $1,565,624 | |
| 6 | BDTX |
Black Diamond Therapeutics, Inc.
|
723,477 | $1,541,006 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,498,860 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
149,900 | $1,293,637 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $349,180 | 221,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $369,070 | 221,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $373,490 | 221,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $136,500 | 150,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $75,555 | 167,900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $208,950 | 417,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $688,657 | 756,766 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $681,766 | 681,766 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,009,013 | 681,766 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $852,124 | 781,766 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $922,483 | 781,766 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,102,290 | 781,766 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,172,649 | 781,766 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $914,666 | 781,766 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $273,082 | 241,666 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $623,098 | 394,366 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,585 | 14,666 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $532,301 | 217,266 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $575,230 | 228,266 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,699,816 | 596,427 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,511,376 | 643,139 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,198,276 | 680,839 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $549,466 | 584,539 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $398,512 | 458,060 | Shares | Sole | 2020-08-31 | |
| 2020-03-31 | $439,102 | 529,039 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||